First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2012-10-30 03:36:53Open Document File Size: 2,72 MBShare Result on FacebookCityPhiladelphia / Baltimore / New York / Cambridge / London / New Haven / /CompanyRoche USA / Eli Lilly / Schering Ag / Cambridge University Press / John Hopkins University Press / Yale University Press / Transition 397 Management Group / Bruno J. Strasser 2 14 Pharma / Life Science Industries / Encoding Capital / Oxford University Press / Roche Holding AG / F. Hoffmann-La Roche & Co. / Merck / Bruno J. Strasser 14 Pharma / Twentieth-Century Pharmaceuticals / Hoffmann / Roche UK / Harvard University Press / /ContinentAmerica / /CountrySwitzerland / France / United Kingdom / Germany / United States / Spain / / /EventFDA Phase / /FacilityYale University / /IndustryTermlaboratory infrastructure / business of biotechnology / chemistry-based pharmaceutical / pharmaceutical industry / biotechnology era / pharmaceutical sector / chemical variants / research management / chemical and pharmacological properties / pharmaceutical activity / company management / molecular biology technologies / chemical extraction / chemical research / biotechnology start-ups / manufacturing / pharmaceutical industries / transformation of the pharmaceutical industry / chemicals / venture capital / century-long networks / chemical synthesis / pharmaceutical discovery / biotechnology / chemical compounds / pharmaceutical / expansion of the management / biological research networks / biotechnology project / dangerous pharmaceutical / century-long continuity of biotechnology / biotechnology revolution / chemical / public relations / chemical strategies / pharmaceutical firms / /MedicalConditiondiphtheria / disease / thalassemia research / /MedicalTreatmentemergency contraception / antibiotics / /OrganizationCambridge University / Roche Research Foundation / Institut d’histoire / FDA / Oxford University / Swiss National Science Foundation / Harvard University / Yale University / Roche.17 Its / Institut für Geschichte / /PersonRobert Bud / Heather Munro Prescott / Frank Huisman / Mehran Ebrahimi / Lawrence D. Barney / Gene Dreams / Jean-Paul Gaudillière / Alfred Pletscher / Albert Caflisch / Catherine Garnier / Alexander Morrison / Max Furter / Sonja Matter / Viviane Quirke / Thomas Casutt / William J. Buxton / Judy Slinn Perspectives / Axel C. Hüntelmann / Otto Isler / Werner Schulemann / María Jesús Santesmases / Placidius A. Plattner / Elmer L. Severinghaus / Alexander Bieri / Robert H. Desmarteau / Alfred D. Chandler Jr. / Raymond P. Ahlquist / Jonathan Simon / /Positionpresident / historian / author / head of chemical research / leader in genetic engineering / the Drug Company-Medical Scientist / managing director / head of medical research / chemist / The Scientist-Entrepreneur / head of research / business historian / first chairman / /ProductPenicillin / FDA drug / /ProvinceOrStateQuebec / Connecticut / /PublishedMediumForeword / /Technologygenetic engineering / Human Genome / molecular biology technologies / recombinant DNA / Recombinant DNA technology / antibodies / biotechnology / Rational drug design / recombinant DNA technologies / Drug Development / /SocialTag |